These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study. Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963 [TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Prince JS; Senac MO Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336 [TBL] [Abstract][Full Text] [Related]
8. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases. Araz N; Okan V; Demirci M; Araz M Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554 [TBL] [Abstract][Full Text] [Related]
9. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections. Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458 [TBL] [Abstract][Full Text] [Related]
10. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Bickford CL; Spencer AP Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184 [TBL] [Abstract][Full Text] [Related]
11. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases]. Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960 [TBL] [Abstract][Full Text] [Related]
12. Biliary precipitation during ceftriaxone therapy: frequency and risk factors. Soysal A; Eraşov K; Akpinar I; Bakir M Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone. Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807 [TBL] [Abstract][Full Text] [Related]
14. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children. Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067 [TBL] [Abstract][Full Text] [Related]
15. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis. Murata S; Aomatsu T; Yoden A; Tamai H Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455 [TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection. Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120 [TBL] [Abstract][Full Text] [Related]
18. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report. Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101 [TBL] [Abstract][Full Text] [Related]
19. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children. Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004 [TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]